News

15 March 2021

BAP Pharma rank 97th in The Sunday Times HSBC International Track 200.

We are delighted to announce that BAP Pharma have ranked in the top 50% (97th) in the 12th annual Sunday Times HSBC International Track 200.

The Sunday Times HSBC International Track 200 ranks Britain’s mid-market private companies with the fastest-growing international sales, measured over their latest two years of available accounts. BAP Pharma recorded a 2-year average international sales growth of 40.92%, with international sales reaching £70.8 million.

Now in their 10th year of trading, and with their existing operations in UK and east coast US, complemented by their new German facility, BAP have returned growth over 40% in each of the last 3 years. Revenues hit more than £160m in 2020. Still managed and run by its founder, Dr Bashir Parkar, Bashir operates a dynamic and vibrant culture. He demands second to none customer service where the company delivers on its promises, without mishap.

“We are proud to be included in The Sunday Times International Track 200, as recognition of our efforts to expand operations internationally and continue to deliver excellence in customer service. This would not have been possible without the support of our loyal customers and the efforts of our amazing staff”.

Dr. Bashir Pakar, Founder and Managing Director of BAP Pharma.

 

This year’s special COVID-19 edition highlighted the important contribution that private companies made during the pandemic.

The table is compiled by Fast Track, who are a leading research and events company, that has created a network of the UK’s top private companies through rankings in The Sunday Times.

You Might Also Like

Walk All Over Cancer Challenge 2021

At the beginning of March 2021, a group of volunteers came together from BAP Pharma Ltd, to form the BAP Steppers. Their aim – to take on the Walk All Over Cancer challenge for Cancer Research UK. The BAP Steppers put on their walking shoes and braved the unpredictable weather,

Walk All Over Cancer Challenge 2021

BAP Pharma awarded EcoVadis Silver Sustainability Rating

BAP Pharma are excited and proud to announce that we have achieved a Silver rating in the recent EcoVadis Sustainability ratings, placing the company within the 90th percentile of all rated companies worldwide. EcoVadis review more than 75,000 companies based on four main areas: Environment Labour & Human Rights Ethics

BAP Pharma awarded EcoVadis Silver Sustainability Rating

Exclusive Agreement For The Supply and Distribution Of Bicillin® LA

BAP Pharma Limited is pleased to announce the signing of an exclusive agreement for the supply and distribution of Bicillin® L-A (Penicillin G Benzathine) to expand access to the product in the UK and Europe (previously only available in the US)   Product Details Bicillin® L-A is a ready-to-use Benzathine

Exclusive Agreement For The Supply and Distribution Of Bicillin® LA